Click here for free access to our latest coronavirus/COVID-19 research, commentary, and news.

Support nonprofit science journalism

Science’s extensive COVID-19 coverage is free to all readers. To support our nonprofit science journalism, please make a tax-deductible gift today.

Donate

Not Now

Ken Garber

Twitter

Latest Stories

Epigenetics comes to RNA

By Ken GarberJul. 5, 2019
Hidden layer of gene control influences everything from cancer to memory

By Ken GarberJul. 1, 2019
Runners-up

By Eric Hand, Gretchen Vogel, et al.Dec. 21, 2018
Blood test may predict cancer immunotherapy benefit

By Ken GarberJun. 29, 2018
Mutation-counting blood test could predict if cutting-edge immunotherapies can beat a cancer

By Ken GarberJun. 27, 2018
A new cancer immunotherapy suffers a setback

By Ken GarberMay. 11, 2018
A promising new cancer drug has hit a major setback, raising questions about whether the field is moving too fast

By Ken GarberMay. 9, 2018
In a major shift, cancer drugs go‘tissue-agnostic’

By Ken GarberJun. 16, 2017
In a major shift, cancer drugs go ‘tissue-agnostic’

By Ken GarberJun. 16, 2017
Protein ‘drops’ may seed brain disease

Oct. 23, 2015
Cancer's copper connections

Jul. 10, 2015
Targeting copper to treat breast cancer

Jul. 10, 2015
The cancer drug that almost wasn't

Aug. 21, 2014
Potential Alzheimer's Drug Spurs Protein Recycling

Apr. 24, 2014
Melanoma Drug Vindicates Targeted Approach

Dec. 18, 2009
Translational Institute Unites Unlikely Partners at Penn

By Ken GarberAug. 17, 2007

Support nonprofit science journalism

Ken Garber

Ken Garber

Latest Stories

Epigenetics comes to RNA

Hidden layer of gene control influences everything from cancer to memory

Runners-up

Blood test may predict cancer immunotherapy benefit

Mutation-counting blood test could predict if cutting-edge immunotherapies can beat a cancer

A new cancer immunotherapy suffers a setback

A promising new cancer drug has hit a major setback, raising questions about whether the field is moving too fast

In a major shift, cancer drugs go‘tissue-agnostic’

In a major shift, cancer drugs go ‘tissue-agnostic’

Protein ‘drops’ may seed brain disease

Cancer's copper connections

Targeting copper to treat breast cancer

The cancer drug that almost wasn't

Potential Alzheimer's Drug Spurs Protein Recycling

Melanoma Drug Vindicates Targeted Approach

Translational Institute Unites Unlikely Partners at Penn

Latest News

Staff Writers

Support nonprofit science journalism

Ken Garber

Ken Garber

Latest Stories

Latest News

Staff Writers

Read the Latest Issue of Science

27 March 2020

Scientific Community

Ecology

Asia/Pacific News

Epidemiology

Medicine/Diseases

Medicine/Diseases